Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

0.8690
+0.01151.34%
Volume:6K
Turnover:5.37K
Market Cap:23.16M
PE:-3.04
High:0.8690
Open:0.8614
Low:0.8599
Close:0.8575
52wk High:3.40
52wk Low:0.7069
Shares:26.65M
Float Shares:21.83M
Volume Ratio:2.37
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2855
EPS(LYR):-0.3933
ROE:-69.86%
ROA:-22.85%
PB:2.25
PE(LYR):-2.21

Loading ...

ABVC BioPharma Q1 EPS $(0.06), Same YoY

Benzinga Earnings
·
May 18

ABVC Biopharma Q1 FY26 net loss widens 79% to $1.69 million

Reuters
·
May 18

ABVC BioPharma delays filing quarterly report for period ended March 31, 2026

Reuters
·
May 16

Press Release: Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301

Dow Jones
·
May 14

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

TIPRANKS
·
May 12

Press Release: Collegium Completes Acquisition of AZSTARYS(R) from Corium Therapeutics

Dow Jones
·
May 12

Yukiguni Maitake Sees FY Net Y2.54B

Dow Jones
·
May 11

Press Release: Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Dow Jones
·
May 07

Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures

TIPRANKS
·
May 07

Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD

TIPRANKS
·
May 04

Regencell Bioscience Holdings Faces Investor Lawsuit Alleging Securities Fraud Tied to DOJ Investigation and Stock Volatility

TIPRANKS
·
May 02

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 30

Humanwell Healthcare Subsidiary Gets China Nod for ADHD Treatment

MT Newswires Live
·
Apr 09

ABVC BioPharma Shareholders Back Board, Equity Plan Changes

TIPRANKS
·
Mar 28

ABVC Biopharma held annual shareholder meeting; quorum reached with 10.6 million shares represented by proxy

Reuters
·
Mar 28

Press Release: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 27

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

GlobeNewswire
·
Mar 26

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating

TIPRANKS
·
Mar 20

Press Release: Collegium to Acquire AZSTARYS(R) from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Dow Jones
·
Mar 19

Press Release: Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Dow Jones
·
Mar 18